Volume is the heartbeat of a move
In the uncertain currents of a retreating market, two established Indian companies — a pharmaceutical giant and a defense manufacturer — have drawn the attention of a technical analyst who sees in their price charts the quiet accumulation of institutional conviction. Sun Pharma and Hindustan Aeronautics, each shaped by different forces, appear to be tracing patterns that seasoned chart readers associate with upward momentum. The recommendation is not born of fundamental reinvention but of the older discipline of reading how money moves — and right now, it appears to be moving in.
- Sun Pharma defied a broad market sell-off by climbing 3.5%, completing a rare inverse head-and-shoulder breakout that signals a potential shift in momentum.
- HAL's 70% rally last year gave way to a deep correction, but the stock found its footing precisely at the golden retracement level — a mathematically significant floor that bulls had been watching.
- Heavy volume on rallies and light volume on pullbacks in both stocks suggest institutional players are quietly building positions, not retreating.
- Geopolitical tensions involving the US, Israel, and Iran are keeping defense spending in focus, giving HAL a fundamental tailwind to match its technical setup.
- Analyst Rajesh Bhosale has set clear entry ranges, stop-losses, and targets for both stocks, framing the trade as a disciplined risk-reward opportunity rather than speculation.
Rajesh Bhosale of Angel One has identified Sun Pharma and Hindustan Aeronautics as two stocks positioned for near-term gains, basing his case on technical chart patterns, volume behavior, and the broader market environment.
Sun Pharma closed the week at ₹1,799, rising 3.5% even as the wider market fell. The stock completed an inverse head-and-shoulder pattern — a formation associated with upward momentum — and did so on surging volumes, which Bhosale reads as evidence of institutional buying. With the price sitting above key moving averages and momentum indicators in positive territory, he recommends entering between ₹1,800 and ₹1,790, with a stop-loss at ₹1,740 and a target of ₹1,950.
HAL tells a different story. After rallying nearly 70% from ₹3,000 to ₹5,100, the stock pulled back and found support at the 61.8% retracement level — the so-called golden ratio. There, it formed a bullish piercing pattern on the weekly chart, and a subsequent RSI crossover on the daily timeframe added further confirmation. Crucially, the recent recovery came on heavy volume while the correction unfolded on lighter trading, suggesting sellers were losing conviction. With defense stocks gaining attention amid US-Israel-Iran tensions, Bhosale sees HAL as well-positioned, recommending entry near ₹4,025 with a stop-loss at ₹3,800 and a target of ₹4,400.
Both calls share a common thread: charts pointing to institutional accumulation, technical patterns aligned with upward momentum, and risk-reward setups that favor buyers. Whether these signals prove prescient will become clear in the weeks ahead.
Rajesh Bhosale, a technical analyst at Angel One, has identified two stocks he believes are positioned for near-term gains: Sun Pharmaceutical Industries and Hindustan Aeronautics Limited. His reasoning rests on a close reading of price charts, volume patterns, and the broader market context in which these companies operate.
Sun Pharma closed the week at ₹1,799, having climbed 3.5 percent while the broader market retreated. What caught Bhosale's attention was the specific shape the stock's price had traced on the chart—an inverse head and shoulder pattern, a formation that technical analysts interpret as a signal of upward momentum. The breakout was not accompanied by thin trading; volumes surged alongside the price move, which Bhosale sees as confirmation that institutional money was flowing into the stock. The price now sits comfortably above the major moving averages that traders use as reference points, and the momentum indicators he monitors remain in positive territory. On these grounds, he recommends buying the stock in the ₹1,800 to ₹1,790 range, with a stop-loss at ₹1,740 and a target price of ₹1,950.
Hindustan Aeronautics presents a different but equally compelling setup. The stock closed at ₹4,025, and its recent history tells a story of sharp appreciation followed by consolidation. Last year, HAL rallied from around ₹3,000 to ₹5,100—a move of roughly 70 percent. That kind of advance typically exhausts itself, and the stock entered a pullback phase. The key detail for Bhosale is where that pullback found its floor: at the 61.8 percent retracement level of the prior rally, a mathematical point that technical traders call the golden ratio. At that level, the stock formed what he identifies as a bullish piercing line pattern on the weekly chart, a two-candle formation that suggests buyers are reasserting control. On the daily timeframe, a minor range breakout has occurred alongside a bullish crossover in the RSI, a momentum oscillator. The volume profile reinforces the picture: the recent rise came with heavy trading, while the preceding corrections saw lighter volume, indicating that sellers were losing conviction while buyers accumulated shares.
Context matters here. Defense stocks have been in focus as tensions between the United States, Israel, and Iran have escalated. HAL, as India's primary aerospace and defense manufacturer, stands to benefit from any sustained geopolitical uncertainty that keeps defense spending elevated. Bhosale sees a favorable risk-reward setup: he recommends buying around ₹4,025 to ₹4,015, with a stop-loss at ₹3,800 and a target of ₹4,400.
Both recommendations rest on the same underlying conviction: that the charts are showing signs of institutional accumulation, that the technical patterns align with upward momentum, and that the risk-reward ratio favors buyers over the near term. Neither stock is a screaming bargain or a turnaround story; both are established companies whose charts suggest the next move is likely to be up. For traders and investors watching these names, the next few weeks will reveal whether these technical signals prove prescient or merely another false signal in an unpredictable market.
Citas Notables
The breakout is supported by a notable increase in volumes, with prices trading well above all key moving averages while oscillators remain positively placed— Rajesh Bhosale, Angel One, on Sun Pharma
The recent rise again with increasing volumes indicates strong accumulation, offering a favorable risk-reward ratio— Rajesh Bhosale, Angel One, on Hindustan Aeronautics
La Conversación del Hearth Otra perspectiva de la historia
Why does volume matter so much to you in these two cases?
Volume is the heartbeat of a move. You can draw any pattern on a chart, but if it happens on thin trading, it's just noise. When Sun Pharma broke out and volumes surged, that told me institutions were buying, not retail traders chasing a rumor. Same with HAL—the rallies came on heavy volume, the pullbacks on light volume. That's the signature of accumulation, not distribution.
The inverse head and shoulder on Sun Pharma—is that a reliable pattern?
It's reliable enough that it appears in textbooks and traders watch for it. But reliable doesn't mean certain. What made me confident here was that the breakout was supported by volume and the price stayed above the moving averages. The pattern alone would be interesting. The pattern plus volume plus price action above key levels—that's when you have conviction.
You mentioned the golden retracement level for HAL. That sounds almost mystical.
It does sound that way, but it's just math. When a stock rallies 70 percent and then pulls back, traders know that certain percentage retracements—38.2, 50, 61.8—are places where buyers often step in. HAL found support right at that 61.8 level. Coincidence? Maybe. But it happens often enough that you have to respect it.
What if geopolitical tensions ease and defense stocks fall out of favor?
Then HAL could break below support and the trade fails. That's why I set a stop-loss at ₹3,800. You're not betting on peace or war. You're reading what the chart is telling you right now and managing your risk if the story changes.
How long do you expect these moves to play out?
Near term—weeks, maybe a couple of months. These aren't long-term holds. The technical setup suggests momentum in the coming period, but charts change. You take the trade when the setup is there, you exit when it breaks.